{
    "root": "0142e692-3e86-48f4-9973-71fa2ccf0963",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Stiolto Respimat",
    "value": "20250221",
    "ingredients": [
        {
            "name": "TIOTROPIUM BROMIDE MONOHYDRATE",
            "code": "L64SXO195N"
        },
        {
            "name": "OLODATEROL HYDROCHLORIDE",
            "code": "65R445W3V9"
        }
    ],
    "indications": "stiolto respimat combination tiotropium bromide , anticholinergic olodaterol , long-acting beta 2 -adrenergic agonist ( laba ) indicated long-term , once-daily maintenance treatment patients chronic obstructive pulmonary disease ( chronic obstructive pulmonary disease ) . ( 1.1 ) important limitations : stiolto respimat indicated treat acute deterioration chronic obstructive pulmonary disease . ( 1.1 ) stiolto respimat indicated treat asthma . ( 1.1 )",
    "contraindications": "oral inhalation . two inhalations stiolto respimat once-daily time day . ( 2 )",
    "warningsAndPrecautions": "stiolto respimat inhalation spray supplied labeled carton containing one stiolto respimat cartridge one stiolto respimat inhaler . stiolto respimat cartridge provided aluminum cylinder tamper protection seal cap . stiolto respimat cartridge intended stiolto respimat inhaler interchanged respimat device delivered product . stiolto respimat inhaler cylindrical shaped plastic inhalation device gray colored body clear base . clear base removed insert cartridge . inhaler contains dose indicator . light green-colored cap written information label gray inhaler body indicate labeled stiolto respimat cartridge . stiolto respimat inhalation spray available : stiolto respimat inhalation spray : 60 metered actuations ( ndc 0597-0155-61 ) stiolto respimat inhalation spray : 10 metered actuations ( ndc 0597-0155-70 ) ( institutional pack ) stiolto respimat cartridge net fill weight least 4 grams used stiolto respimat inhaler , designed deliver labeled number metered actuations preparation . labeled number actuations dispensed inhaler , respimat locking mechanism engaged actuations dispensed . assembly , stiolto respimat inhaler discarded latest 3 months first locking mechanism engaged , whichever comes first . keep reach children . spray eyes .",
    "adverseReactions": "laba , including stiolto respimat , without inhaled corticosteroid contraindicated patients asthma [ ( 5.1 ) ] . stiolto respimat indicated treatment asthma . stiolto respimat contraindicated patients hypersensitivity tiotropium , ipratropium , olodaterol , component product [ ( 5.4 ) ] . trials postmarketing experience tiotropium , immediate hypersensitivity , including angioedema ( including swelling lips , tongue , throat ) , itching , rash reported . hypersensitivity also reported trials stiolto respimat .",
    "indications_original": "STIOLTO RESPIMAT is a combination of tiotropium bromide, an anticholinergic and olodaterol, a long-acting beta 2 -adrenergic agonist (LABA) indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1.1 ) Important limitations: STIOLTO RESPIMAT is NOT indicated to treat acute deterioration of COPD. ( 1.1 ) STIOLTO RESPIMAT is NOT indicated to treat asthma. ( 1.1 )",
    "contraindications_original": "For oral inhalation only. Two inhalations of STIOLTO RESPIMAT once-daily at the same time of day. ( 2 )",
    "warningsAndPrecautions_original": "STIOLTO RESPIMAT Inhalation Spray is supplied in a labeled carton containing one STIOLTO RESPIMAT cartridge and one STIOLTO RESPIMAT inhaler.\n                  The STIOLTO RESPIMAT cartridge is provided as an aluminum cylinder with a tamper protection seal on the cap. The STIOLTO RESPIMAT cartridge is only intended for use with the STIOLTO RESPIMAT inhaler and should not be interchanged with any other RESPIMAT device delivered product.\n                  The STIOLTO RESPIMAT inhaler is a cylindrical shaped plastic inhalation device with a gray colored body and a clear base. The clear base is removed to insert the cartridge. The inhaler contains a dose indicator. The light green-colored cap and the written information on the label of the gray inhaler body indicate that it is labeled for use with the STIOLTO RESPIMAT cartridge.\n                  STIOLTO RESPIMAT Inhalation Spray is available as:\n                  \n                     STIOLTO RESPIMAT Inhalation Spray: 60 metered actuations (NDC 0597-0155-61)\n                     STIOLTO RESPIMAT Inhalation Spray: 10 metered actuations (NDC 0597-0155-70) (institutional pack)\n                  \n                  The STIOLTO RESPIMAT cartridge has a net fill weight of at least 4 grams and when used with the STIOLTO RESPIMAT inhaler, is designed to deliver the labeled number of metered actuations after preparation for use.\n                  When the labeled number of actuations has been dispensed from the inhaler, the RESPIMAT locking mechanism will be engaged and no more actuations can be dispensed.\n                  After assembly, the STIOLTO RESPIMAT inhaler should be discarded at the latest 3 months after first use or when the locking mechanism is engaged, whichever comes first.\n                  Keep out of reach of children. Do not spray into eyes.",
    "adverseReactions_original": "Use of a LABA, including STIOLTO RESPIMAT, without an inhaled corticosteroid is contraindicated in patients with asthma [see Warnings and Precautions (5.1)].  STIOLTO RESPIMAT is not indicated for the treatment of asthma.\n                  STIOLTO RESPIMAT is contraindicated in patients with a hypersensitivity to tiotropium, ipratropium, olodaterol, or any component of this product [see Warnings and Precautions (5.4)].\n                  In clinical trials and postmarketing experience with tiotropium, immediate hypersensitivity reactions, including angioedema (including swelling of the lips, tongue, or throat), itching, or rash have been reported. Hypersensitivity reactions were also reported in clinical trials with STIOLTO RESPIMAT."
}